1-4 of 4
Roy Smith
Close
Sort by
Journal Articles

Long-Term Safety and Efficacy of Sutimlimab in Patients with Chronic Immune Thrombocytopenia

Catherine M. Broome, Alexander Röth, MD, David J. Kuter, MD, Marie Scully, MD, Roy Smith, Jennifer Wang, Xiaoyu Jiang, Caroline Reuter, Ahmed Daak, William Hobbs
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-139663
Published: 2020
Journal Articles

Inhibition of the Classical Pathway of Complement with Sutimlimab in Chronic Immune Thrombocytopenic Purpura Patients without Adequate Response to Two or More Prior Therapies

Catherine M Broome, MD, Alexander Röth, MD PhD, David J. Kuter, Marie Scully, Roy Smith, Jennifer Wang, Caroline Reuter, William Hobbs
Journal: Blood
Blood (2019) 134 (Supplement_1): 898.
https://doi.org/10.1182/blood-2019-122210
Published: 2019
Journal Articles

Analysis of Patients Mislabeled with Heparin Induced Thrombocytopenia

Apurva Pandey, MD, Christine Ann Garcia, MD MPH, Roy Smith, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3619.
https://doi.org/10.1182/blood.V130.Suppl_1.3619.3619
Published: 2017
Journal Articles

Thirty Day Readmissions Due to Venous Thromboembolism in Patients Discharged with Syncope

Sudeep K Siddappa Malleshappa, MD, Kathan Dilipbhai Mehta, MBBS, MPH, Gautham K Velecha, MBBS, Smit Patel, MBBS, MPH, Smith Giri, MBBS, Roy Smith, MD, Rahul Atul Parikh, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4642.
https://doi.org/10.1182/blood.V130.Suppl_1.4642.4642
Published: 2017